|
Name |
Urs-12-en-24-oic acid, 3-oxo-, methyl ester
|
| Molecular Formula | C31H48O3 | |
| IUPAC Name* |
methyl 4,6a,6b,8a,11,12,14b-heptamethyl-3-oxo-1,2,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydropicene-4-carboxylate
|
|
| SMILES |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C(=O)OC)C)C)C2C1C)C)C
|
|
| InChI |
InChI=1S/C31H48O3/c1-19-11-14-27(3)17-18-29(5)21(25(27)20(19)2)9-10-22-28(4)15-13-24(32)31(7,26(33)34-8)23(28)12-16-30(22,29)6/h9,19-20,22-23,25H,10-18H2,1-8H3
|
|
| InChIKey |
DWWPSRGTSZHWME-UHFFFAOYSA-N
|
|
| Synonyms |
Urs-12-en-24-oic acid, 3-oxo-, methyl ester; Methyl 3-oxours-12-en-23-oate #; Urs-12-en-24-oic acid, 3-oxo-, methyl ester, (+)-
|
|
| CAS | NA | |
| PubChem CID | 612822 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 468.7 | ALogp: | 8.2 |
| HBD: | 0 | HBA: | 3 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 43.4 | Aromatic Rings: | 5 |
| Heavy Atoms: | 34 | QED Weighted: | 0.228 |
| Caco-2 Permeability: | -5.032 | MDCK Permeability: | 0.00001110 |
| Pgp-inhibitor: | 0.915 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.725 |
| 30% Bioavailability (F30%): | 0.924 |
| Blood-Brain-Barrier Penetration (BBB): | 0.768 | Plasma Protein Binding (PPB): | 99.18% |
| Volume Distribution (VD): | 1.257 | Fu: | 2.26% |
| CYP1A2-inhibitor: | 0.017 | CYP1A2-substrate: | 0.79 |
| CYP2C19-inhibitor: | 0.078 | CYP2C19-substrate: | 0.973 |
| CYP2C9-inhibitor: | 0.145 | CYP2C9-substrate: | 0.185 |
| CYP2D6-inhibitor: | 0.04 | CYP2D6-substrate: | 0.308 |
| CYP3A4-inhibitor: | 0.737 | CYP3A4-substrate: | 0.917 |
| Clearance (CL): | 18.672 | Half-life (T1/2): | 0.029 |
| hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.273 |
| Drug-inuced Liver Injury (DILI): | 0.041 | AMES Toxicity: | 0.025 |
| Rat Oral Acute Toxicity: | 0.573 | Maximum Recommended Daily Dose: | 0.344 |
| Skin Sensitization: | 0.007 | Carcinogencity: | 0.147 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.198 |
| Respiratory Toxicity: | 0.967 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005544 | ![]() |
0.521 | D0P2IT | ![]() |
0.325 | ||
| ENC005527 | ![]() |
0.496 | D0I2SD | ![]() |
0.311 | ||
| ENC001833 | ![]() |
0.405 | D03MTN | ![]() |
0.308 | ||
| ENC002033 | ![]() |
0.395 | D0Q4SD | ![]() |
0.285 | ||
| ENC004077 | ![]() |
0.373 | D0EP0C | ![]() |
0.281 | ||
| ENC003286 | ![]() |
0.356 | D0Z1XD | ![]() |
0.275 | ||
| ENC001949 | ![]() |
0.351 | D04SFH | ![]() |
0.270 | ||
| ENC003457 | ![]() |
0.343 | D04GJN | ![]() |
0.270 | ||
| ENC005963 | ![]() |
0.329 | D07BSQ | ![]() |
0.268 | ||
| ENC002012 | ![]() |
0.324 | D08TEJ | ![]() |
0.265 | ||